Background and purpose: To determine whether iron deposition in deep brain nuclei assessed using high-pass filtered phase imaging plays a role in motor disease severity in Parkinson's disease (PD). Methods: Seventy patients with mild to moderate PD and 20 age-and gender-matched healthy volunteers (HVs) underwent susceptibility-weighted imaging on a 3 T magnetic resonance imaging scanner. Phase shifts (radians) in deep brain nuclei were derived from high-pass filtered phase images and compared between groups. Analysis of clinical laterality and correlations with motor severity (Unified Parkinson's Disease Rating Scale, Part III, UPDRS-III) were performed. Phase shifts (in radians) were compared between HVs and three PD subgroups divided according to UPDRS-III scores using analysis of covariance, adjusting for age and regional area. Results: Parkinson's disease patients had significantly (P < 0.001) higher radians than HVs bilaterally in the putamen, globus pallidus and substantia nigra (SN). The SN contralateral to the most affected side showed higher radians (P < 0.001) compared to the less affected side. SN radians positively correlated with UPDRS-III and bradykinesiaÀrigidity subscores, but not with tremor subscores. ANCOVA followed by post hoc Bonferroni-adjusted pairwise comparisons revealed that SN radians were significantly greater in the PD subgroup with higher UPDRS-III scores compared to both lowest UPDRS-III PD and HV groups (P < 0.001). Conclusions: Increased nigral iron accumulation in PD appears to be stratified according to disease motor severity and correlates with symptoms related to dopaminergic neurodegeneration. This semi-quantitative in vivo iron assessment could prove useful for objectively monitoring PD progression, especially in clinical trials concerning iron chelation therapies.
Introduction
Iron plays an important role in Parkinson's disease (PD) neurodegeneration. Postmortem and in vitro studies have demonstrated links between iron accumulation and the cardinal pathological features of PD, the loss of dopamine neurons in the substantia nigra (SN) pars compacta [1] and the presence of a-synuclein-rich Lewy bodies [2] . Free ferrous iron (Fe 2+ ) acts as a catalyst in a reaction with hydrogen peroxide (Fenton reaction), producing highly toxic reactive oxygen species and ferric iron (Fe 3+ ) that lead to oxidative-stress-related damage to cellular components including proteins, lipids and DNA [3] . To relieve potential toxicity, excess ferrous iron within deep brain nuclei is accumulated and transported into the core of apoferritin molecules where it is oxidized and safely stored in high concentrations in the ferric state [4] . Since ferritin (iron-containing apoferritin) is highly paramagnetic and indeed one of the only non-haem iron molecules present in sufficient quantity to cause local field inhomogeneities [4, 5] , magnetic resonance imaging (MRI) can be used to measure ferritin-bound ferric iron in vivo. Given that the biosynthetic rate of apoferritin is modulated by the availability of free iron [6, 7] , changes in ferritin-related MR signal are reflective of alterations in iron load.
In vivo iron quantification using MRI relaxometry (T2*, R2*) or susceptibility-weighted imaging (SWI) consistently demonstrates increased SN iron levels in patients with PD relative to healthy volunteers (HVs) [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , whilst results pertaining to striatal regions such as the caudate nucleus, putamen and globus pallidus appear highly heterogeneous [8] [9] [10] [11] [12] [13] [14] [15] [16] . Several studies have observed relationships between increased nigral iron accumulation, disease duration and motor severity [12] [13] [14] 18] although to our knowledge there are currently no cross-sectional studies that have evaluated whether significant changes in iron accumulation exist between different stages of disease burden in mesencephalic or striatal nuclei. In addition, it remains unclear as to the effect of iron accumulation on differing motor symptoms, with the two studies investigating tremor and akinetic/rigid predominance yielding conflicting results [16, 17] .
Consequently the goal of this study was (i) to evaluate differences in iron accumulation in deep brain nuclei between PD groups of varying motor severity and (ii) to investigate the association between motor symptomatology and iron load. Phase images obtained as part of an SWI protocol were used because they contain information on the tissue magnetic susceptibility distribution, a property shown to be influenced by ferritin and haemosiderin (breakdown product of ferritin) and which correlates with iron concentration postmortem [14, 19] . Conventional relaxometry techniques are also affected by background field inhomogeneities such as tissue water content and airÀtissue interfaces; thus phase images represent a more direct means to estimate iron [4] . This work demonstrates the value of iron quantification as an objective means by which patients can be monitored and stratified, particularly from the viewpoint of developing iron modifying therapies.
Methods

Subjects
Seventy non-demented mild to moderate stage PD patients and 20 age-and gender-matched HVs were included in this study (see Table S1 for recruitment information). The diagnosis of PD was performed by movement disorder specialists according to the Parkinson's UK Brain Bank criteria [20] , excluding atypical parkinsonism, concomitant vascular load, history of cognitive impairment and neurodegenerative disorders other than PD.
Data were collected under the TransEuro and PaMIR studies, funded by FP7 and Parkinson's UK respectively, and carried out in accordance with the Declaration of Helsinki after approval from the National Research Ethics Service Committee. All participants gave written informed consent before participation.
Motor assessment
Motor symptomatology was measured using the Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III). Patients were instructed to withdraw from medication 24 h prior to assessment. Off-medication UPDRS-III scores were then subdivided into tremor (sum of items [15] [16] [17] [18] and bradykinesiaÀrigidity subscores (sum of items 2-9 and 14). Levodopaequivalent daily dose (LEDD) was calculated.
Susceptibility-weighted imaging
Susceptibility-weighted images were acquired on a 3 T Siemens Magnetom Trio system with a 32-channel phased-array head coil running a T2-weighted threedimensional gradient-echo sequence (SWI: TR = 28 ms, TE = 20 ms, flip angle 15°, bandwidth 120 Hz per pixel, matrix size 294 9 320, FoV = 230 9 230 mm, GRAPPA acceleration factor 2). Seventy-two slices of 1.9 mm thickness and slice gap 20% were obtained in an interleaved order parallel to the anteriorÀposterior commissural line in the left-hand reference system. A small number of participants (four PD, seven HVs) underwent a modified SWI protocol in which 88 slices of 0.9 mm thickness with a 20% slice gap were acquired. Phase images were reconstructed automatically on the Siemens workstation (Syngo MR B17 software, SWI version 1, Siemens, Erlangen, Germany), which included application of a 64 9 64 high-pass filter to remove low spatial frequency effects.
Regions of interest analysis
Manual region of interest (ROI) delineation was performed by a trained investigator (AMB) on both PD and HV high-pass filtered phase images using SPIN (Signal Processing in Nuclear Magnetic Resonance; MRI Institute, Detroit, MI, USA). All study subjects were anonymized prior to delineation, thus blinding group and disease severity. ROIs were hand drawn on a single axial slice and included head of the caudate nucleus, putamen and globus pallidus (Fig. 1) . The SN was delineated on the third axial slice ventral to the most dorsal aspect of the red nucleus. For images acquired under the modified SWI protocol, the fifth axial slice ventral to the most dorsal aspect of the red nucleus was used (Fig. S1 ). Independent sample t tests showed no significant differences in SN radians between the two SWI protocols for either group (P > 0.05; Table S2 ). Subjects with microvascular lesions or physiological calcifications in the globus pallidus were not included in the analysis.
Mean phase-shift values, number of voxels, standard deviations and regional areas were extracted for each ROI unilaterally before averaging to obtain bilateral data. Phase-shift values were converted to radians according to the formula provided for the Siemens lefthanded system: radians = (/ À 2048)p/2048 [21] . 
Statistical analysis
All statistical analyses were performed using SPSS statistical software (version 22.0 SPSS Inc., Chicago, IL, USA).
Group demographics and bilateral radians for each region were compared between PD and HVs using independent t tests. ROIs showing a significant difference were considered for analyses of covariance (ANCOVA) in which PD patients, subdivided into three disease severity groups using UPDRS-III tertile calculations (Table 1) , were compared to the HV group, adjusting for age and regional area and followed with post hoc Bonferroni-adjusted pairwise comparisons.
To assess hemispheric iron load differences in the PD group, radians for clinically most/least affected sides, as indicated by UPDRS-III laterality items, were compared for each region using independent t tests.
Pearson's correlation coefficient was used to assess relationships between each ROI and measures of disease severity (disease duration, UPDRS-III total, tremor and bradykinesia/rigidity). Correlations were considered significant only for P < 0.05 following BenjaminiÀHochberg false discovery rate (FDR) adjustment.
Results
Participants
Clinical and demographic data are summarized in Table 1 . There were no significant differences in age (P = 0.347) between PD and HVs. Although the male: female ratio was higher in the PD group (P = 0.039), no significant gender differences in iron accumulation were found.
As expected, PD subgroups exhibited significant differences in motor severity, disease duration, LEDD and Hoehn and Yahr scores (Table 1 ). There were no significant differences between subgroups for age or gender.
Phase-shift analysis
ShapiroÀWilk's test revealed that putaminal and pallidal radians were not normally distributed (P < 0.05). Square root transformations were therefore applied to the putamen and logarithmic transformation to the globus pallidus. The PD group showed significantly more radians in the putamen, globus pallidus and SN (P < 0.001) compared to HVs (Fig. 2) . No significant difference was found in the caudate nucleus. ANCOVA including HV and PD subgroups indicated main effects of motor severity in the putamen (F = 6.346, P < 0.001), globus pallidus (F = 7.998, P < 0.001) and SN (F = 65.008, P < 0.001; Table 2 ). Post hoc Bonferroni-adjusted pairwise comparisons showed that the radians in all three PD subgroups were significantly higher than HVs in the globus pallidus (P = 0.025, P < 0.001 and P = 0.001 respectively) and SN (P < 0.001, P < 0.001 and P < 0.001 respectively; Table 2 ). Putaminal radians were significantly higher in PD subgroups 1 and 2 (P = 0.006, P < 0.001) compared to HVs. Pairwise comparisons between the PD subgroups revealed significance only in the SN, i.e. PD group 1 showed significantly lower radians compared to PD groups 2 (P = 0.049) and 3 (P = 0.001). Although PD group 3 showed the most radians in the SN, no statistically significant difference was found compared with PD group 2 (P = 0.236; Fig. 3 ).
Analysis of clinical laterality
The SN contralateral to the clinically most affected side showed more radians (P < 0.001) compared to the least affected side. No other significant results were found.
Correlations with disease duration and motor severity Pearson's correlation analysis revealed significant positive correlations between SN radians and total UPDRS-III (r = 0.420, P < 0.001) and bradykinesiaÀrigidity subscores (r = 0.407, P = 0.001) but not with tremor (r = 0.219, P = 0.071; Fig. 4 ). Correlations remained significant after BenjaminiÀHochberg FDR correction for multiple comparisons.
Within the HV group, SN radians positively correlated with age (r = 0.533, P = 0.016).
Validation of phase-shift data
To validate whether phase-shift data provide a quantitative measure of iron, Pearson's correlations were conducted between deep brain grey matter nuclei radians from the HV group and the distribution of nonhaem iron at autopsy, as reported by Hallgren and Sourander [22] . A positive correlation was found after exclusion of the caudate nucleus due to spatial discordance with regard to regional iron measurements (r = 0.874, P = 0.01; Fig. S2 ).
Discussion
This cross-sectional MRI study evaluated regional iron deposition in deep brain nuclei, using high-pass filtered phase images to quantify average phase shift (radians) in a large cohort of PD patients as well as age-matched HVs.
Higher levels of iron, as measured using radians, were found in the SN of PD patients relative to the HV group. Further, when PD groups were subdivided Figure 2 Comparison of radians between PD (grey bars) and HVs (white bars). CN, caudate nucleus; Put, putamen; GP, globus pallidus; SN, substantia nigra. ***P < 0.001, **P < 0.01. 
MOTOR ASSOCIATIONS OF IRON ACCUMULATION IN PD
according to UPDRS-III score, the SN showed a stratified distribution in which iron accumulation increased with motor severity. The SN is particularly vulnerable to abnormal increases in iron. Neuromelanin (NM), which under normal conditions acts as a neuroprotective iron chelator, is released into the extracellular space as a result of nigral cell death. Extracellular NM then releases ferric iron, which in turn promotes oxidative stress, microglial activation and further neuronal death [23] . Indeed, increased nigral iron has been demonstrated in imaging studies using both SWI and relaxometry techniques [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Recent longitudinal studies have also shown that changes in SN iron accumulation over time correlate with changes in motor severity [24, 25] . Our design provides further evidence that this effect is not limited to increases within individuals but that significant changes can be seen between patients at different stages of disease. It is noted that, although there was an increase in iron from moderate to high PD groups, this was not significant, suggesting that the rate of accumulation may decrease as the disease progresses. These findings cannot be explained by age differences, which are well known to correlate with nigral iron levels [26] , nor between-patient nigral size, since both were added as covariates in our model.
Increased iron deposition was also found in the putamen and globus pallidus, although no difference was found in the caudate nucleus. Results relating to striatal mineralization have been highly variable, with several studies reporting increases [8, 11, 13, 15] , reductions [9, 10] or normal levels [12, 14, 16] in PD. One possible explanation for this heterogeneity could be the presence of calcifications in the striatum, which may cause SWI and relaxometry techniques to underestimate iron levels. Recently, however, Ulla et al. [24] demonstrated in an early PD cohort that, whilst there was a significant increase in R2* signal in the caudal putamen between baseline and 3-year follow-up compared to HVs, the rostral putamen remained at normal levels. Thus, the heterogeneity of results within the literature may be attributable to a rostro-caudal gradient of mineralization, which in turn may be dependent on disease duration. In addition, our data, although non-significant, show a trend for an initial increase of iron accumulation from low to moderate PD motor severity followed by a decrease from moderate to high motor severity in both the putamen and globus pallidus. Interestingly, this trend is in accordance with Ryvlin et al. [9] who suggested that mineralization in these regions inversely correlates with disease duration when the duration of illness is above 10 years. In contrast to the SN, it is clear that the mechanism behind striatal iron accumulation is not yet understood. Further longitudinal studies with patients followed up to the point of moderate to high motor severity are required to characterize the trajectory of striatal mineralization in PD more accurately.
Substantia nigra iron has previously been shown to correlate strongly with disease duration and motor severity [12] [13] [14] 18] . Here, it is found that this Figure 3 Box and whisker plot displaying ANCOVA results for the SN.PD group 1, UPDRS-III = 19.3 AE 3.11; PD group 2, UPDRS-III = 29.27 AE 3.13; PD group 3, UPDRS-III = 44.60 AE 6.42. Ad hoc Bonferroni-adjusted pairwise comparison significance levels indicated as follows: ***P < 0.001, **P < 0.01, *P < 0.05. Figure 4 Pearson's correlations of SN radians with UPDRS-III, bradykinesiaÀrigidity and tremor scores. relationship may be driven by bradykinesia/rigidity symptomatology, since although a strong relationship was found between these measures no association with tremor was identified. Bradykinesia and rigidity symptoms result as a direct consequence of dopaminergic nigral neurodegeneration [27] , which is associated with regional iron accumulation [1] . In contrast, tremor not only reflects dopaminergic nigro-striatal degeneration but may also be associated with serotoninergic and noradrenergic pathology [28] . Indeed, it was recently found that dopaminergic presynaptic terminal availability as well as storage capacity in the putamen and caudate nucleus were negatively associated with bradykinesia and rigidity scores, but not with tremor (Li W, Lao-Kaim NP, Roussakis AA, Martin-Bastida A, Loane C, Valle-Guzman N, Kefalopoulou Z, Politis M, Foltynie T, Barker RA, Piccini P, unpublished observations). Bunzeck et al. found a significant association between striatal iron accumulation and tremor symptomatology, suggesting that putaminal iron may be used as a predictor for tremor dominance in early PD [17] . However, their measures were collected in the 'on' medication state whilst our assessments were conducted in the 'off' medication state in order to avoid the confounding effect of variable clinical benefit with respect to tremor. Thus our data suggest that iron levels in the SN may be a feasible biomarker of bradykinesia and rigidity progression in PD.
The use of high-pass filtered phase imaging may be of therapeutic interest. Iron chelators that cross the bloodÀbrain barrier, such as deferiprone, used mainly for peripheral haematological disorders, show a disease-modifying effect in animal models of PD [29] . So far, two randomized clinical trials with this drug have been conducted in PD patients, showing small reductions in motor severity after 6-12 months of treatment without major medication-related side effects [30] (Martin-Bastida A, Ward RJ, Newbould R, Piccini, P, Sharp D, Kabba C, Patel MC, Spino M, Conelly J, Fernando T, Crichton RR, Dexter DT unpublished observations). However, MR relaxometry data were not consistent between these studies, detecting different degrees of regional chelation. Conventional relaxometry techniques (T2* and R2*) estimate iron load in vivo using gradient echo sequences that are sensitive to variations in transverse relaxation times/rates between different tissues and that are affected by both macroscopic and microscopic magnetic field inhomogeneities [31] . However, images produced using these methods can be affected by changes in tissue water content and other background field inhomogeneities such as those resulting from airÀtissue interfaces [4, 31] . In contrast, SWI sequences, whilst also utilizing T2* weighting, involve the collection of both magnitude and phase images using a three-dimensional velocity-compensated gradient echo sequence. In particular, phase images contain information on the tissue magnetic susceptibility distribution. Since paramagnetic molecules such as ferritin and haemosiderin influence the local magnetic field and therefore the phase of the MR signal [31] , phase offers greater specificity to quantifying brain iron load. Phase images are also more robust to the presence of noise [32] , and the removal of low spatial frequency artefacts that could otherwise obscure inter-tissue phase differences (using a high-pass filter) [33] further improves its sensitivity to detecting abnormal iron levels. Thus, high-pass filtered phase images are a good alternative for monitoring the effects of iron chelators longitudinally.
There are some limitations with our study. First, the slice with the highest iron content was analysed in order to avoid background artefacts. Although no ROI size differences were found between PD and HVs, this method may not reflect the iron content of the entirety of each nucleus.
Secondly, although it is well documented that the pars compacta and pars reticulata present differential levels of mineralization, the SN was analysed without further segmentation. Postmortem studies including those immunostaining for calbindin D 28K [34] have provided valuable information on the definition of nigral compartments based on dopamine-cell-independent anatomical landmarks. However, translation to MRI segmentation is not straightforward owing to technical considerations (acquisition volume, slice orientation and thickness) and imperfect correspondence between anatomically defined nigral distribution and that observed on T2-weighted images [35, 36] . Nevertheless, attempts have been made to manually separate the nigra albeit with significant methodological variation [12, 24] , highlighting disagreement on best localization procedures. More sophisticated techniques have recently been developed involving multimodal analysis of both SWI and NM-sensitive T1-weighted MRI (magnetization transfer) with which reduced NM pigmentation has been demonstrated in the SN pars compacta in PD with very high sensitivity and specificity [37, 38] . However, the authors note a spatial overlap of 12.6% AE 4.6% between the two SN volumes further reflecting the difficulty of accurately segmenting the SN [39] . Given the inability of phase images to resolve intra-nigral boundaries, the SN was delineated as a whole in order to maintain the accuracy of our measurements, although it is acknowledged that this was at the cost of specificity and conclusiveness with regard to the level of mineralization for each sub-region and their relationship to PD pathology. Higher MR field strength and the use of quantitative susceptibility mapping [40] which can further reduce phase image artefacts may provide greater spatial validity with respect to iron and improve the accuracy with which nigral compartments can be interrogated.
In summary, our results demonstrate that the degree of iron accumulation in PD is stratified according to disease severity in the SN but not in striatal sub-regions and that nigral iron is associated with the severity of bradykinesia and rigidity rather than tremor. Phase imaging techniques could be an important tool for monitoring clinical progression and establishing the efficacy and neuroprotective effects of iron chelation therapies in PD patients of variable clinical phenotype. 
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